Related references
Note: Only part of the references are listed.Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor
Ahmed Elwakeel et al.
CANCERS (2021)
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
Satish K. Ramraj et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
Anissa Nofita Sari et al.
CANCERS (2020)
Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity
Ritta Jubran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Novel Caffeic Acid Phenethyl Ester-Mortalin Antibody Nanoparticles Offer Enhanced Selective Cytotoxicity to Cancer Cells
Jia Wang et al.
CANCERS (2020)
Molecular Insights Into Withaferin-A-Induced Senescence: Bioinformatics and Experimental Evidence to the Role of NFκB and CARF
Priyanshu Bhargava et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
Sukant Garg et al.
MARINE DRUGS (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
Jayarani F. Putri et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Anticancer Activity in Honeybee Propolis: Functional Insights to the Role of Caffeic Acid Phenethyl Ester and Its Complex With gamma-Cyclodextrin
Yoshiyuki Ishida et al.
INTEGRATIVE CANCER THERAPIES (2018)
Anticancer activity of the supercritical extract of Brazilian green propolis and its active component, artepillin C: Bioinformatics and experimental analyses of its mechanisms of action
Priyanshu Bhargava et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Mortalin-mediated and ERK-controlled targeting of HIF-1α to mitochondria confers resistance to apoptosis under hypoxia
Ilias Mylonis et al.
JOURNAL OF CELL SCIENCE (2017)
Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells
Ming-Bo Huang et al.
ONCOTARGET (2017)
Relevance of mortalin to cancer cell stemness and cancer therapy
Chae-Ok Yun et al.
SCIENTIFIC REPORTS (2017)
Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer
Ryan A. Denu et al.
BMC CANCER (2016)
Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown
Su-Hyeong Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
Renu Wadhwa et al.
JOURNAL OF CANCER (2016)
Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells
Jung-Sun Lee et al.
ONCOTARGET (2015)
A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2
Ammara Abdullah et al.
ONCOTARGET (2015)
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
Nupur Nigam et al.
PLOS ONE (2015)
Fucoxanthin induces growth arrest and apoptosis in human bladder cancer T24 cells by up-regulation of p21 and down-regulation of mortalin
Linbo Wang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
Utilizing adenovirus vectors for gene delivery in cancer
Dayananda Kasala et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Synthesis and Initial Evaluation of YM-08, a Blood-Brain Barrier Permeable Derivative of the Heat Shock Protein 70 (Hsp70) Inhibitor MKT-077, Which Reduces Tau Levels
Yoshinari Miyata et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer
Perri Rozenberg et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Custer C. Deocaris et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Secretion Modification Region-Derived Peptide Disrupts HIV-1 Nef's Interaction with Mortalin and Blocks Virus and Nef Exosome Release
Martin N. Shelton et al.
JOURNAL OF VIROLOGY (2012)
Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
Huanjie Yang et al.
PLOS ONE (2012)
Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences
Kirti Vaishnavi et al.
PLOS ONE (2012)
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy
W-J Lu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin
Wen-Jing Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Crosstalk between Raf/MEK/ERK and PI3K/AKT in Suppression of Bax Conformational Change by Grp75 under Glucose Deprivation Conditions
Ling Yang et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
mot-2-Mediated Cross Talk between Nuclear Factor-κB and p53 Is Involved in Arsenite-Induced Tumorigenesis of Human Embryo Lung Fibroblast Cells
Yuan Li et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins - Identification of additional interacting regions
Ohad Iosefson et al.
FEBS LETTERS (2010)
Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling
Nashi Widodo et al.
PLOS ONE (2010)
Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation
Jung Hwa Oh et al.
APOPTOSIS (2008)
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V. Powers et al.
CANCER CELL (2008)
Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses
Nashi Widodo et al.
CANCER LETTERS (2008)
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
J. Y. Yoo et al.
GENE THERAPY (2008)
Withania somnifera:: An Indian ginseng
S. K. Kulkarni et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Internalizing antibody-based targeted gene delivery for human cancer cells
Maki Shiota et al.
HUMAN GENE THERAPY (2007)
A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice
Fayaz Malik et al.
LIFE SCIENCES (2007)
The tumor proteasome is a primary target for the natural anticancer compound withaferin a isolated from Indian Winter Cherry
Huanjie Yang et al.
MOLECULAR PHARMACOLOGY (2007)
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth
Ji Young Yoo et al.
MOLECULAR THERAPY (2007)
Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex
N. Sen et al.
CELL DEATH AND DIFFERENTIATION (2007)
An anti body-conjugated internalizing quantum dot suitable for long-term live imaging of cells
Zeenia Kaul et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2007)
Mortalin controls centrosome duplication via modulating centrosomal localization of p53
Z. Ma et al.
ONCOGENE (2006)
Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis
Rena Wadhwa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
VJN Bykov et al.
ONCOGENE (2005)
Short interfering RNAs as a tool for cancer gene therapy
M Izquierdo
CANCER GENE THERAPY (2005)
Ad-mTERT-Δ19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner
E Kim et al.
HUMAN GENE THERAPY (2003)
Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts
SC Kaul et al.
EXPERIMENTAL CELL RESEARCH (2003)
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy
J Kim et al.
CANCER GENE THERAPY (2002)
Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma
S Guruswamy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75
QT Ran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
